European healthcare stocks surge as U.S. Pfizer deal reduces some uncertainty

Core Viewpoint - European healthcare stocks experienced a significant increase following an announcement from Pfizer and U.S. President Donald Trump regarding a deal to lower prescription drug prices in the Medicaid program in exchange for tariff relief [1] Group 1 - Pfizer, a U.S.-based drugmaker, has agreed to lower prescription drug prices as part of a negotiation with the U.S. government [1] - The agreement is specifically related to the Medicaid program, which provides health coverage to low-income individuals [1] - The announcement led to a notable rise in European healthcare stocks on the following day [1]